Published in J Infect Dis on September 01, 1985
Conservation of epitopes in the oligosaccharide portion of the lipooligosaccharide of Haemophilus influenzae type b. Infect Immun (1987) 2.06
Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influenzae. Infect Immun (1987) 1.87
Biosynthesis pathway of ADP-L-glycero-beta-D-manno-heptose in Escherichia coli. J Bacteriol (2002) 1.60
Antigenic characterization of the oligosaccharide portion of the lipooligosaccharide of nontypable Haemophilus influenzae. Infect Immun (1987) 1.59
Identification of a chromosomal locus for expression of lipopolysaccharide epitopes in Haemophilus influenzae. Infect Immun (1989) 1.56
Phase-variable lipopolysaccharide structures enhance the invasive capacity of Haemophilus influenzae. Infect Immun (1990) 1.45
Haemophilus influenzae type b lipooligosaccharide: stability of expression and association with virulence. Infect Immun (1987) 1.38
Identification of a new locus involved in expression of Haemophilus influenzae type b lipooligosaccharide. Infect Immun (1994) 1.31
Cloning and expression in Escherichia coli of a Haemophilus influenzae type b lipooligosaccharide synthesis gene(s) that encodes a 2-keto-3-deoxyoctulosonic acid epitope. Infect Immun (1990) 1.19
Role of complement in mouse macrophage binding of Haemophilus influenzae type b. J Clin Invest (1990) 1.16
Effect of mutations in lipooligosaccharide biosynthesis genes on virulence of Haemophilus influenzae type b. Infect Immun (1990) 1.12
Lipopolysaccharide gel profiles of Haemophilus influenzae type b are not stable epidemiologic markers. J Clin Microbiol (1986) 1.07
Involvement of the Haemophilus ducreyi gmhA gene product in lipooligosaccharide expression and virulence. Infect Immun (1998) 1.05
Altered lipopolysaccharide characteristic of the I69 phenotype in Haemophilus influenzae results from mutations in a novel gene, isn. J Bacteriol (1996) 1.04
Characterization of a mutant of Haemophilus influenzae type b lacking the P2 major outer membrane protein. Infect Immun (1990) 1.02
The rfaE gene from Escherichia coli encodes a bifunctional protein involved in biosynthesis of the lipopolysaccharide core precursor ADP-L-glycero-D-manno-heptose. J Bacteriol (2000) 1.02
Molecular cloning of the Haemophilus influenzae gmhA (lpcA) gene encoding a phosphoheptose isomerase required for lipooligosaccharide biosynthesis. J Bacteriol (1996) 1.02
Identification of phosphorylated 3-deoxy-manno-octulosonic acid as a component of Haemophilus influenzae lipopolysaccharide. Biochem J (1987) 1.00
OpsX from Haemophilus influenzae represents a novel type of heptosyltransferase I in lipopolysaccharide biosynthesis. J Bacteriol (2005) 0.90
Functional analysis of the glycero-manno-heptose 7-phosphate kinase domain from the bifunctional HldE protein, which is involved in ADP-L-glycero-D-manno-heptose biosynthesis. J Bacteriol (2005) 0.89
Role of lipooligosaccharide in virulence of the Brazilian purpuric fever clone of Haemophilus influenzae biogroup aegyptius for infant rats. Infect Immun (1993) 0.88
Challenge of investigating biologically relevant functions of virulence factors in bacterial pathogens. Philos Trans R Soc Lond B Biol Sci (2000) 0.85
Dissociation of virulence and protection from infection by mutant analysis in Haemophilus influenzae type b. Infect Immun (1987) 0.81
Functional genomics of pathogenic bacteria. Philos Trans R Soc Lond B Biol Sci (2002) 0.80
Pathogenesis of meningitis: experimental studies on the molecular basis of Haemophilus influenzae infection. Infection (1984) 0.75
Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science (2000) 16.04
The gal locus from Haemophilus influenzae: cloning, sequencing and the use of gal mutants to study lipopolysaccharide. Mol Microbiol (1992) 9.22
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science (2000) 7.41
Detection of Pneumocystis carinii with DNA amplification. Lancet (1990) 5.50
Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis (1974) 4.94
Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun (1973) 4.80
PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol (1994) 4.08
Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae. Rev Infect Dis (1990) 4.06
Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. Lancet (1997) 3.69
Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet (1992) 3.60
The molecular mechanism of phase variation of H. influenzae lipopolysaccharide. Cell (1989) 3.60
Electrophoretic heterogeneity and interstrain variation of the lipopolysaccharide of Haemophilus influenzae. J Infect Dis (1983) 3.44
DNA repeats identify novel virulence genes in Haemophilus influenzae. Proc Natl Acad Sci U S A (1996) 3.38
The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants. J Infect Dis (1981) 3.24
Clonal population structure of encapsulated Haemophilus influenzae. Infect Immun (1988) 3.03
Cloning of chromosomal DNA from Haemophilus influenzae. Its use for studying the expression of type b capsule and virulence. J Clin Invest (1984) 2.94
Virulence and transmissibility of pathogens: what is the relationship? Trends Microbiol (1997) 2.91
Population-based study of non-typable Haemophilus influenzae invasive disease in children and neonates. Lancet (1993) 2.88
Genetics of spontaneous, high-frequency loss of b capsule expression in Haemophilus influenzae. Infect Immun (1985) 2.84
Simple sequence repeats in the Helicobacter pylori genome. Mol Microbiol (1998) 2.75
Evolutionary genetics of the encapsulated strains of Haemophilus influenzae. Proc Natl Acad Sci U S A (1988) 2.68
The bex locus in encapsulated Haemophilus influenzae: a chromosomal region involved in capsule polysaccharide export. Mol Microbiol (1990) 2.49
Capsule loss in H. influenzae type b occurs by recombination-mediated disruption of a gene essential for polysaccharide export. Cell (1988) 2.49
Repeat-associated phase variable genes in the complete genome sequence of Neisseria meningitidis strain MC58. Mol Microbiol (2000) 2.44
Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin. Mol Biochem Parasitol (1990) 2.42
Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. Microbiol Mol Biol Rev (1997) 2.42
Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase. Lancet (1981) 2.41
Pathogenesis of neonatal Escherichia coli meningitis: induction of bacteremia and meningitis in infant rats fed E. coli K1. Infect Immun (1977) 2.39
The role of pili in the interactions of pathogenic Neisseria with cultured human endothelial cells. Mol Microbiol (1991) 2.36
The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis (1995) 2.31
Clinical laboratory challenges in the recognition of Leuconostoc spp. J Clin Microbiol (1988) 2.27
Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells. Mol Microbiol (1993) 2.26
Detection and quantitation of bacteremia in childhood. J Pediatr (1977) 2.21
Opc- and pilus-dependent interactions of meningococci with human endothelial cells: molecular mechanisms and modulation by surface polysaccharides. Mol Microbiol (1995) 2.18
The length of a tetranucleotide repeat tract in Haemophilus influenzae determines the phase variation rate of a gene with homology to type III DNA methyltransferases. Mol Microbiol (2000) 2.13
"Contractile interstitial cells" in pulmonary alveolar septa: a possible regulator of ventilation-perfusion ratio? Ultrastructural, immunofluorescence, and in vitro studies. J Cell Biol (1974) 2.11
Haemophilus influenzae meningitis in infant rats: role of bacteremia in pathogenesis of age-dependent inflammatory responses in cerebrospinal fluid. J Infect Dis (1977) 2.09
Characterization of repetitive sequences controlling phase variation of Haemophilus influenzae lipopolysaccharide. J Bacteriol (1990) 2.08
Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial. JAMA (2000) 2.07
Surface determinants of Haemophilus influenzae pathogenicity: comparative virulence of capsular transformants in normal and complement-depleted rats. J Infect Dis (1983) 2.06
The simple sequence contingency loci of Haemophilus influenzae and Neisseria meningitidis. J Clin Invest (2001) 2.04
The Haemophilus influenzae capsulation gene cluster: a compound transposon. Mol Microbiol (1991) 2.03
Infection with vancomycin-resistant "streptococci" due to Leuconostoc species. J Infect Dis (1988) 2.01
The role of a repetitive DNA motif (5'-CAAT-3') in the variable expression of the Haemophilus influenzae lipopolysaccharide epitope alpha Gal(1-4)beta Gal. Mol Microbiol (1993) 1.98
Capsulation in distantly related strains of Haemophilus influenzae type b: genetic drift and gene transfer at the capsulation locus. J Bacteriol (1990) 1.98
Common organization of chromosomal loci for production of different capsular polysaccharides in Haemophilus influenzae. J Bacteriol (1989) 1.96
Variable expression of the Opc outer membrane protein in Neisseria meningitidis is caused by size variation of a promoter containing poly-cytidine. Mol Microbiol (1994) 1.96
Haemophilus influenzae type b disease in the Oxford region. Arch Dis Child (1989) 1.95
Serotype specificity and immunogenicity of the capsular polymer of Haemophilus pleuropneumoniae serotype 5. Infect Immun (1987) 1.94
Molecular analysis of a locus for the biosynthesis and phase-variable expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis. Mol Microbiol (1995) 1.93
Haemophilus influenzae bacteremia and meningitis resulting from survival of a single organism. Proc Natl Acad Sci U S A (1978) 1.88
Sialic acid in the lipopolysaccharide of Haemophilus influenzae: strain distribution, influence on serum resistance and structural characterization. Mol Microbiol (1999) 1.88
Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom. JAMA (2000) 1.83
Use of the complete genome sequence information of Haemophilus influenzae strain Rd to investigate lipopolysaccharide biosynthesis. Mol Microbiol (1996) 1.79
Pseudomonas cepacia: an emerging pathogen in chronic granulomatous disease. J Pediatr (1986) 1.79
IgA1 proteases of Haemophilus influenzae: cloning and characterization in Escherichia coli K-12. Proc Natl Acad Sci U S A (1983) 1.77
Genes involved in Haemophilus influenzae type b capsule expression are part of an 18-kilobase tandem duplication. Proc Natl Acad Sci U S A (1986) 1.76
Contribution of lipopolysaccharide to pathogenicity of Haemophilus influenzae: comparative virulence of genetically-related strains in rats. Microb Pathog (1986) 1.75
Absence in Helicobacter pylori of an uptake sequence for enhancing uptake of homospecific DNA during transformation. Microbiology (1999) 1.73
Expression of the Opc protein correlates with invasion of epithelial and endothelial cells by Neisseria meningitidis. Mol Microbiol (1992) 1.72
Fatal adenovirus disease and human immunodeficiency virus infection. Pediatr Infect Dis J (1990) 1.69
Capsulation and gene copy number at the cap locus of Haemophilus influenzae type b. J Bacteriol (1988) 1.67
Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin Infect Dis (2000) 1.65
Haemophilus somnus: Bovine Reproductive and Respiratory Disease. Can Vet J (1986) 1.64
Composition and antigenic activity of the oligosaccharide moiety of Haemophilus influenzae type b lipooligosaccharide. Infect Immun (1985) 1.62
Genetic characterization of a Tn5-disrupted glycosyltransferase gene homolog in Brucella abortus and its effect on lipopolysaccharide composition and virulence. Infect Immun (1999) 1.62
Protective ability and specificity of convalescent serum from calves with Haemophilus somnus pneumonia. Infect Immun (1987) 1.61
Indirect enzyme-linked immunosorbent assay for the quantitation of the type-specific antigen of Haemophilus influenzae b: a preliminary report. J Pediatr (1980) 1.59
Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis (1998) 1.57
Identification of a chromosomal locus for expression of lipopolysaccharide epitopes in Haemophilus influenzae. Infect Immun (1989) 1.56
Efficacy of Haemophilus influenzae type B conjugate vaccine in Oxford region. Lancet (1992) 1.55
Experimentally revised repertoire of putative contingency loci in Neisseria meningitidis strain MC58: evidence for a novel mechanism of phase variation. Mol Microbiol (2003) 1.54
The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis. Microbiology (1999) 1.53
Region II of the Haemophilus influenzae type be capsulation locus is involved in serotype-specific polysaccharide synthesis. Mol Microbiol (1995) 1.52
Distinct mechanisms of interactions of Opc-expressing meningococci at apical and basolateral surfaces of human endothelial cells; the role of integrins in apical interactions. Mol Microbiol (1994) 1.51
Underestimation of meningococci in tonsillar tissue by nasopharyngeal swabbing. Lancet (2000) 1.50
Infection rates of Broviac-Hickman catheters and implantable venous devices. Am J Dis Child (1988) 1.50
Microbial genetics. The tinkerer's evolving tool-box. Nature (1997) 1.48
Activation of the alternative complement pathway by Haemophilus influenzae type B. Infect Immun (1977) 1.46
Phase-variable lipopolysaccharide structures enhance the invasive capacity of Haemophilus influenzae. Infect Immun (1990) 1.45
Haemophilus influenzae disease in the White Mountain Apaches: molecular epidemiology of a high risk population. Pediatr Infect Dis (1985) 1.45
Conservative management of an echovirus 11 outbreak in a neonatal unit. Lancet (1989) 1.45
The carrier state: Haemophilus influenzae. J Antimicrob Chemother (1986) 1.44
Limited genetic diversity of Haemophilus influenzae (type b). Microb Pathog (1987) 1.44
The infant rat as a model of bacterial meningitis. J Infect Dis (1977) 1.44
Invasive Haemophilus influenzae type b disease in the Oxford region (1985-91). Arch Dis Child (1993) 1.42
Invasive pneumococcal disease in England and Wales: vaccination implications. J Infect Dis (2000) 1.42
Actinobacillus pleuropneumoniae RTX-toxins: uniform designation of haemolysins, cytolysins, pleurotoxin and their genes. J Gen Microbiol (1993) 1.42
Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom. Arch Dis Child (1989) 1.42
Cloning and molecular analysis of the galE gene of Neisseria meningitidis and its role in lipopolysaccharide biosynthesis. Mol Microbiol (1993) 1.42
Killing of Brucella abortus by bovine serum. Infect Immun (1988) 1.41
A physical map of the genome of Haemophilus influenzae type b. J Gen Microbiol (1990) 1.40
Immunogenicity of routine vaccination against diphtheria, tetanus, and Haemophilus influenzae type b in Asian infants born in the United Kingdom. Arch Dis Child (2005) 1.39
The molecular basis of pathogenicity in Haemophilus influenzae: comparative virulence of genetically-related capsular transformants and correlation with changes at the capsulation locus cap. Microb Pathog (1989) 1.38